TIMOTHY KUNTZ: Open Payments
NPI 1790814630 · PORTLAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,581 in 92 payments from 18 companies in 2025. Trend: 2023 $1,727 · 2024 $2,245 · 2025 $1,581
Food & beverage: $1,581
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $267 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $220 |
| Novo Nordisk Inc | 10 | $219 |
| AstraZeneca Pharmaceuticals LP | 9 | $159 |
| Corcept Therapeutics | 11 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $114 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Lilly USA, LLC | 4 | $62 |
| Sumitomo Pharma America, Inc. | 3 | $59 |
| PFIZER INC. | 2 | $50 |
Products named: XIFAXAN, Korlym, UBRELVY, Ozempic, CAPLYTA, AIRSUPRA, QULIPTA, Auvelity.
Industry payments across TN — which companies pay providers there.
